USPTO serial 79360076
TME PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TME PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products; | ACTIVE | — |
| 005 | Medicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications; | ACTIVE | — |
| 042 | Science and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and devices for the medical sector and research in the fields of chemistry, biology, biophysics, medicine, biochemistry, genetics, genetic engineering, bacteriology; scientific experiments and analyses; surveying; chemistry services, namely, laboratory research in the field of chemistry, biotechnology, medicine; chemical laboratories; medical laboratory services | ACTIVE | — |
| 044 | Medical services in the field of medicine; medical and clinical examinations; pharmaceutical advice; | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TME Pharma AG
- Other trademarks owned by TME Pharma AG
- Other trademarks owned by TME Pharma AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TME PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 12, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 11, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 25, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 10, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 15, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 29, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 29, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 29, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 29, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |